Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acetyl-L-carnitine for symptomatic diabetic neuropathy.

Literature DB >> 7744218

Acetyl-L-carnitine for symptomatic diabetic neuropathy.

A Quatraro, P Roca, C Donzella, R Acampora, R Marfella, D Giugliano.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Insulin
Acetylcarnitine

Year: 1995 PMID： 7744218 DOI： 10.1007/BF02369363

Source DB: PubMed Journal: Diabetologia ISSN： 0012-186X Impact factor: 10.122

× No keyword cloud information.

6 in total

1. Acetylcarnitine: on the relationship between structure and function.

Authors: R L Sass; P Werness
Journal: Biochem Biophys Res Commun Date: 1973-12-10 Impact factor: 3.575

2. Acetyl-L-carnitine acutely administered raises beta-endorphin and cortisol plasma levels in humans.

Authors: E Martignoni; F Facchinetti; G Sances; F Petraglia; G Nappi; A R Genazzani
Journal: Clin Neuropharmacol Date: 1988-10 Impact factor: 1.592

3. Peptide alterations in autonomic diabetic neuropathy prevented by acetyl-L-carnitine.

Authors: A Gorio; A M Di Giulio; B Tenconi; L Donadoni; E Germani; A Bertelli; P Mantegazza; F Maccari; M T Ramacci
Journal: Int J Clin Pharmacol Res Date: 1992

4. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.

Authors: M J Young; A J Boulton; A F MacLeod; D R Williams; P H Sonksen
Journal: Diabetologia Date: 1993-02 Impact factor: 10.122

5. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats.

Authors: N E Cameron; M A Cotter; V Archibald; K C Dines; E K Maxfield
Journal: Diabetologia Date: 1994-05 Impact factor: 10.122

6. Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.

Authors: J I Malone; S Lowitt; N Corsico; Z Orfalian
Journal: Int J Clin Pharmacol Res Date: 1992

6 in total

13 in total

Review 1. Peripheral diabetic neuropathy. Current recommendations and future prospects for its prevention and management.

Authors: D Fedele; D Giugliano
Journal: Drugs Date: 1997-09 Impact factor: 9.546

2. Comparison of the effects of aminoguanidine and L-carnitine treatments on somatosensorial evoked potentials in alloxan-diabetic rats.

Authors: O Yildiz; M Ozata; A Ozkardeş; G Deniz; M Yildirimkaya; A Corakçi; M Yardim; M A Gündoğan
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1996-10 Impact factor: 3.000

3. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).

Authors: D Ziegler; M Hanefeld; K J Ruhnau; H P Meissner; M Lobisch; K Schütte; F A Gries
Journal: Diabetologia Date: 1995-12 Impact factor: 10.122

4. Thioctic acid and acetyl-L-carnitine in the treatment of sciatic pain caused by a herniated disc: a randomized, double-blind, comparative study.

Authors: Antonio Memeo; Mario Loiero
Journal: Clin Drug Investig Date: 2008 Impact factor: 2.859

5. Tolerability and efficacy of L-acetylcarnitine in patients with peripheral neuropathies: a short-term, open multicentre study.

Authors: D D Grandis
Journal: Clin Drug Investig Date: 1998 Impact factor: 2.859

Review 6. Acetyl-L-carnitine in neuropathic pain: experimental data.

Authors: Santina Chiechio; Agata Copani; Robert W Gereau; Ferdinando Nicoletti
Journal: CNS Drugs Date: 2007 Impact factor: 5.749

7. L-Acetylcarnitine in the Treatment of Patients with Peripheral Neuropathies : A Short Term, Double-Blind Clinical Study of 426 Patients.

Authors: D De Grandis; L Santoro; P Di Benedetto
Journal: Clin Drug Investig Date: 1995-12 Impact factor: 2.859